Landsberg Bennett & Dubbaneh’s AstraZeneca AZN Stock Holding History

Landsberg Bennett & Dubbaneh’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.61M	Sell	13,480 -8,533	-39%	-$993K	0.21%	108
2021 Q2	$2.65M	Buy	22,013 +395	+2%	+$43.3K	0.34%	80
2021 Q1	$2.14M	Buy	21,618 +267	+1%	+$26.8K	0.31%	86
2020 Q4	$2.13M	Buy	21,351 +508	+2%	+$53.8K	0.33%	81
2020 Q3	$2.3M	Buy	20,843 +9,154	+78%	+$1.02M	0.4%	76
2020 Q2	$1.24M	Buy	+11,689	New	+$1.21M	0.26%	88

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Landsberg Bennett & Dubbaneh's AZN Position: Q3 2021 in Review

Landsberg Bennett & Dubbaneh reduced its AstraZeneca (AZN) stake by 39% in Q3 2021, selling an estimated $993K and leaving 13,480 shares worth $1.61M. The position accounts for 0.21% of the portfolio, ranked #108.

Landsberg Bennett & Dubbaneh first reported a position in AZN in Q2 2020 and has held it in 6 quarters since. The position peaked at $2.65M in Q2 2021. 906 funds tracked by Wall St. Rank hold AZN as of Q3 2021.

Landsberg Bennett & Dubbaneh held 13,480 shares of AstraZeneca worth $1.61M as of Q3 2021.
Landsberg Bennett & Dubbaneh sold 8,533 AstraZeneca shares in Q3 2021, an estimated $993K.
AstraZeneca made up 0.21% of Landsberg Bennett & Dubbaneh's portfolio in Q3 2021, its #108 holding.
Landsberg Bennett & Dubbaneh first reported a position in AstraZeneca in Q2 2020 and has held it in 6 quarters since.
Landsberg Bennett & Dubbaneh's AstraZeneca position peaked at $2.65M in Q2 2021.
906 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2021.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q3 2021, filed 29 Oct 2021.